Snapshot Science

In this Snapshot Science, researchers use high-throughput assays to characterize thousands of variants associated with Alagille syndrome.

Selpercatinib is the first targeted cancer therapy for pediatric patients 2 years of age and older with RET gene alterations.

CHOP researchers identify biomarkers for early detection of high-grade ovarian cancer.

Sleep promotion, along with diet and exercise, may be another non-pharmacologic option to help reduce hypertension in pediatric patients.

Researchers from CHOP and Penn sought to characterize types of resident advocacy to tailor more effective training curriculums.

Researchers from CHOP and Penn reveal that the microbiome and immune system play a key role in the non-genetic transfer of phenotypes to offspring.

Learn how the NAD metabolite controls how well T and B cells can detect their antigens, leading to quicker immune responses.

With the help of an artificial intelligence deep-learning algorithm called CytoCommunity, researchers better understand how specific cell groups in tissues organize to support tissue function.

CHOP researchers test novel system to help patients with severe complication related to congenital heart disease avoid open heart surgery.

Researchers gained insight into how some patients develop resistance to CD20-targeted immunotherapies for certain blood cancers and describe how their findings might offer alternative treatment options.